Username Password
S&P 500: 1,317.45 Change: +0.03%
wdg1R1
wdg1R1
P&P Score: 0.00
Stats
At least 5 active picks are required to calculate a P&P score.
About Me
Real name wdg1R1
Favorites
wdg1R1 has no favorites
Groups
wdg1R1 has no groups
Highlighted Picks
Most Recent  01/11/12
BUY    SHPGY   $88.48
SHIRE PLC - AMERICAN DEPOSITARY SHAR   +0.14%
With 2 new indications for Vyvanse coming in the near future, current profits for Vyvanse and Intuniv ahead of predicted gains, and the advancement of…more
Most Successful  01/11/12
BUY    SHPGY   $88.48
SHIRE PLC - AMERICAN DEPOSITARY SHAR   -13.86%
With 2 new indications for Vyvanse coming in the near future, current profits fo…more
Least Successful  01/11/12
BUY    SHPGY   $88.48
SHIRE PLC - AMERICAN DEPOSITARY SHAR   -13.86%
With 2 new indications for Vyvanse coming in the near future, current profits fo…more
Recent Posts
Most Recent Blog Post
wdg1R1 has no blog posts
Most Recent Comments

wdg1R1 has no recent comments

Picks

Open
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
01/11/2012 SHPGY Rating: 0 BUY Week or Less $100.74 $88.48
(+0.14%)
- -12.17% +1.69% -13.86 view
Closed
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
All
Start Date Ticker Rating Call Time Frame Start Price Today (change) End Price Stock Gain S&P Gain Points End Date Analysis
01/11/2012 SHPGY Rating: 0 BUY Week or Less $100.74 $88.48
(+0.14%)
- -12.17% +1.69% -13.86 view
Commentary
BUY: SHIRE PLC - AMERICAN DEPOSITARY SHAR (SHPGY)
Start Price: $100.74
Points: -13.86
Created: 01/11/2012
With 2 new indications for Vyvanse coming in the near future, current profits for Vyvanse and Intuniv ahead of predicted gains, and the advancement of the biopharma industry within healthcare, BUY it. This stock has a 72/105 range and is only going up. Plan to possibly sell but not within the next 3 years.

Comments: 0 | Comment

Recs:
 
Sponsored Links